Enclomiphene is defined as a selective estrogen receptor modulator used primarily to stimulate ovulation in women with hormonal infertility. It functions by binding to estrogen receptors in the hypothalamus and increasing the release of gonadotropin-releasing hormone. This receptor agonism leads to enhanced secretion of follicle-stimulating hormone and luteinizing hormone from the pituitary gland. The resulting hormonal surge promotes the development and maturation of ovarian follicles. The pharmacodynamic effect of Enclomiphene is achieved through competitive antagonism of estrogenic feedback thereby restoring ovulatory cycles. Its mechanism of action is rooted in selective modulation of estrogen receptors to amplify endogenous reproductive signaling pathways.

Enclomiphene is a selective estrogen receptor modulator that enhances the body's natural production of testosterone. It works by blocking estrogen receptors in the hypothalamus and pituitary, which reduces negative feedback on the hypothalamic-pituitary-gonadal axis. This inhibition stimulates the release of gonadotropin-releasing hormone, luteinizing hormone, and follicle-stimulating hormone. The increased gonadotropin levels promote leydig cell activity in the testes, leading to higher testosterone synthesis. Elevated testosterone supports normal male secondary sexual characteristics and improves hormonal balance in clinical settings. Because it targets only specific receptor subtypes, Enclomiphene produces a more controlled hormonal response compared with traditional aromatase inhibitors or exogenous testosterone.

Enclomiphene is a selective estrogen receptor modulator used primarily in research settings. It can cause hot flashes which resemble those experienced during hormonal fluctuations. Some users report visual disturbances such as blurred vision or floaters. Headaches and dizziness are also reported in a minority of individuals. Mild gastrointestinal discomfort including nausea or abdominal cramping has been noted. Mood changes such as irritability or anxiety have been observed but are generally transient.

Hot flashes may occur in some individuals taking Enclomiphene. Abdominal cramping or discomfort is sometimes reported. Nausea and mild vomiting can appear during treatment. Headaches are occasionally experienced by users. Breast tenderness or enlargement may be noted. Dizziness or lightheadedness can happen, especially when rising quickly. Some people notice changes in vision such as blurred or double vision.